Stay updated with breaking news from High Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on
MG Comet EV is solution for most of the mobility challenges that we face in our day-to-day life. You can find more about it in our extensive review
/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsung's Byooviz and...
/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsung's Byooviz and...
Gurugram (Haryana) [India], December 27 (ANI/BusinessWire India): India is now facing a significant burden from the rising cancer incidence rate, which is continually climbing. According to estimates, India will record 19 to 20 lakh cancer cases by the end of 2022, although the actual incidence is 1.5 to 3 times higher, a lot of which goes undocumented. In 2020, the combined age-standardised rate for all cancers, excluding non-melanoma skin cancer, was 190 per 100,000, and men had a greater rate of developing cancer (206.9 per 100,000) than women (178.1 per 100,000). Unfortunately, this number...